Maryland
Prescription drug spending and prescribing in Maryland, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $4.5B for prescriptions written in Maryland, the 24th most of 52 states and territories, and 3.8% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $4.5B
- Medicaid drugs, 2025: $1.7B
- Opioid share of claims: 3.8%
- Life-science raises, 2 years: $508M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Maryland | United States | Difference |
|---|---|---|---|
| Opioids | 3.8% | 3.5% | +6% |
| Antibiotics | 4.5% | 4.4% | +1% |
| Antipsychotics | 2.1% | 1.7% | +21% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Maryland's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Oxycodone Hcl | 2.3× | 300,655 |
| Fluphenazine Hcl | 2.2× | 6,651 |
| Bictegrav/Emtricit/Tenofov Ala | 2.2× | 25,118 |
| Oxycodone Myristate | 2.0× | 10,070 |
| Cefuroxime Axetil | 1.9× | 30,275 |
| Candesartan Cilexetil | 1.9× | 12,864 |
| Spironolact/Hydrochlorothiazid | 1.8× | 5,385 |
| Rabeprazole Sodium | 1.8× | 7,243 |
| Buprenorphine Hcl/Naloxone Hcl | 1.8× | 45,641 |
| Tretinoin | 1.8× | 6,641 |
Biggest Medicaid Drugs
What Maryland's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
81 Form D raises by companies based in Maryland in the last two years; the 10 largest. See all raises- Georgiamune, Inc.$93M · Biotech · Aug 17, 2026
- Kaigene, Inc.$55M · Biotech · Oct 14, 2026
- Theradaptive, Inc.$36M · Biotech · Aug 4, 2026
- Porter Cares, Inc.$35M · Other health care · Apr 4, 2025
- Medcura, Inc.$29M · Biotech · Jul 25, 2025
- NextCure, Inc.$22M · Biotech · Dec 10, 2025
- Senseonics Holdings, Inc.$20M · Other health care · May 29, 2025
- CraniUS LLC$19M · Biotech · Mar 6, 2026
- Pep2Tango Therapeutics, Inc.$17M · Biotech · Nov 21, 2024
- Gliknik Inc$15M · Biotech · Aug 21, 2025
State Attorney General Health-Care Cases
Antitrust cases Maryland joined, newest first; see every case- United States and Plaintiff States v. UnitedHealth et al. (D. Md. 1:24-cv-03267-JKB)2025 · Final judgment
- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)2019 · Settled
- California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)2018 · Settled
- FTC and Plaintiff States v. Mallilnckrodt Ard Inc. (formerly Questcor), No. 1:17-cv-00120 (D.D.C. Jan. 18, 2017)2017 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- Connecticut et al. v. Teva Pharmaceuticals et al. Civ. Action No. (D.Conn. Dec. 15, 2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG